The objective of this study is to assessment the postmenopausal bleeding (PMB), and investigated their causes, correlation with variable socio-demographic status. A 140-women complaining of PMB were enrolled in this study, each patient had a proper questionnaire filled in, with appropriate investigations that included; ultrasonography, Pap smear, colposcopy with cervical biopsy and endometrial curettage to take endometrial biopsy for histopathology. Nearly all cases were married 135 (96.4%), most of them were obese and overweight 97(69.3%), 43(30.7%) were having normal body mass index. Various etiology of PMB were found in this study; endometrial cancer (9.3%), cervical cancer (0.7%), atrophic endometritis (7.1%), atrophic vaginitis (2.8%), endometrial hyperplasia (45%), cervicitis-CIN (15.7%), cervical polyp (12.8%), and endometrial polyp (18.6%). Bleeding from benign causes and of endometrial cancer occurs at fifth decade and sixth decade of life, while from cervical cancer occurs at seventh decade. The pattern of PMB; mild bleeding significantly higher in cervicitis-CIN; moderate bleeding more in endometrial polyp and significantly higher than mild and sever bleeding; while severe bleeding was significantly associated in endometrial cancer. Duration of PMB had a vast range (4 days to 5 years). 24.83% of cases had prolonged bleeding > 6months, (48.7%) with endometrial hyperplasia, (12.8%) had endometrial cancer. The endometrial cancer present in 10% of the patients with recurrent PMB.
Introduction
The term menopause is derived from the Greek Menos (month) and Pausis (cessation) is defined as the last menstrual period [1] . The diagnosis can only be made retrospectively after a minimum of 1 year"s amenorrhea, or 6months according to some [2] . In most women, menopause occurs between the ages of 50 and 55 years, with an average age of 51.5years. PMB is defined as bleeding that occurs after 12 months of amenorrhea in middle-aged women [3] . An arbitrary time limit of one year"s amenorrhea is generally set but some prefer to reduce the period to 6 months [4] . Neither normal (functional) bleeding nor dysfunctional bleeding should occur after the menopause. Atrophic or proliferative endometrium is not unusual. Secretary patterns should not occur unless the patient has resumed ovulation or has received progesterone therapy. PMB is more likely to be caused by pathologic disease than is bleeding in younger women and must always be investigated [3] . Approximately 10% of these PMB have a gynecological malignancy. Women should be regarded as having malignancy until proved otherwise. Around 10% of women with PMB will have primary or secondary malignancy; endometrial cancer (80%), cervical cancer or rarely an ovarian tumor [5] . PMB accounts for a significant proportion of gynecological referrals and occurs in approximately 3% of postmenopausal women [6] . The incidence of PMB is strongly correlated with the time since menopause. The estimated incidence was 409/1000 person-years immediately after the first 12 months of amenorrhea following the menopause, falling to 42/1000 person-years more than 3 years after the menopause [7] . The risk of endometrial carcinoma in women with PMB rises with age from approximately 1% at the age of 50 years to approximately 25% at the age 80 years [8] . In patients who have had only one episode of slight PMB, it is common (12-50%) not to find any abnormality. Of patients with negative findings who have bled only once before curettage, 70-80% do not bleed again afterwards. , to assess atrophic changes in the vagina and to note any suspicious lesions, lacerations or foreign bodies. A bimanual pelvic examination is necessary to look for the size, position, mobility, contour and tenderness of the uterus. In addition, a general examination should be performed to look for signs of systemic illness [11, 12, 14] .
Evaluation of uterine bleeding in
3. Basic Laboratory Evaluation: All women who experience PMB must be evaluated for endometrial cancer since age is a significant risk factor for this disorder, mainly by Transvaginal Sonography (TVS) [17, 18] , Saline infusion sonohysterography (SIS) [19] , Dilatation and curettage (D&C) [20] , Endometrial biopsy and aspiration [21] , Hysteroscopy, Cervical Cytology [22] . The aim of the study is to find out common causes of PMB, determine correlation between socio-demographic factors with the causes of PMB, and detect the relation and risk factors related to cervical and endometrial cancer. Table ( 2) shows that endometrial hyperplasia is a major cause of postmenopausal bleeding (45%), while endometrial polyp comes next (18.6%) followed by cervisitis CIN (15.7%) and endocervical polyp (12.8%).
Patient and method

Study design
Frequency percentage of different etiologies
While the frequency percentage of liomyomas (12.1%), endometrial cancer was (9.3%), atrophic endometritis and atrophic vaginitis (9.9%), the reminder include adenomyosis (2.8%) ,endometrial polyp (5.5%) and cervical cancer was (0.7% ) Table (2). American Journal of BioMedicine AJBM 2016;4(6):263-280 doi:10.18081/2333-5106/016-6/263-280 Table 5 .
Different etiology-Amount of PMB
In table 5 shows that mild bleeding significantly higher in cervicitis-CIN, In endometrial polyp the moderate bleeding is significantly higher than mild and sever bleeding ,while endometrial cancer was significantly associated with amount of bleeding were most cases had severe bleeding. Table (6), shows that the duration of PMB was between (1week-1month) in (33.1%) of cases and it was between (1month-6months) and in (31.2%), (15.9%) of cases had PMB of (>6months-12months) duration, the reminder cases were (10.8%) presented within (a week) duration and only (8.9%) had PMB of (more than 1year duration). Duration of PMB had a vast range (4 days to 5 years). (24.83%) of cases had prolonged bleeding >6months, of these (48.7%) had endometrial hyperplasia and (12.8%) had endometrial cancer. In this study the incidence of recurrent PMB was 25.47%, of these 40% had endometrial hyperplasia, while 10% of the patients with recurrent PMB had endometrial cancer. The incidence of recurrent bleeding was (25.47%); most of these patients had a previous dilatation and curettage. 
Discussion
PMB is considered as an important and alarming symptom both to the patient and the gynecologist [23] . The incidence of PMB declines with succeeding years after menopause and that the incidence of endometrial carcinoma increases as the age of the patient with PMB increases [24] and as observed by other [25] . The result of this study is comparable to this observation, the frequency of bleeding after seventy years are decrease; only ten cases were reported. The most common age for occurrence of bleeding in post menopause in this study is fifth decade and is comparable to the result of other study [26] . Endometrial cancer is one of the most common gynecological malignancies, the peak incidence for endometrial cancer is between (65-75years) of age (12) which is higher than the result of this study (the peak incidence for endometrial cancer is between (60-69 years) of age), also this result is lower than the peak incidence for endometrial cancer [27] (which is between 65-74years) but, it is higher than other study which showed peak incidence between50-54years. Excessive estrogen is associated with most of the risk factors that have been linked to endometrial carcinoma [28] . Either endogenous or from exogenous source, this is in regard to early menarche and late menopause [29] . All 13 cases with endometrial cancer had menarche below 14 years of age and 9 out of 13 had menopause after 50 years. Nulliparity and infertility associated with
anovulation is considered a risk factor for endometrial cancer, pregnancy reduces the risk of endometrial cancer by 30% after the first birth and by 25% with each subsequent birth [30] , in this study all cases of endometrial carcinoma were married, among those one of them was infertile, the parity range from 4-9, so there is no evidence for the risk to decline with increasing number of birth [31] . Exogenous estrogen: in this study all cases were non user of HRT, because usage of HRT isn"t common in our community. Obesity is another risk factor studied. Increased body mass index is one of the major risk factors for the PMB and hence malignancy [32] . Seven cases with endometrial cancer were obese &4 cases were overweight. 30 out of 63 cases with hyperplasia were obese &17 were overweight. Another risk factor for endometrial cancer is a family history of endometrial cancer.
The greatest risk appears to be in first degree relatives, genetic disease represent up to 10% of cases [33] , 3 cases with endometrial cancer have a family history of related cancers, 2 with breast cancer & one case with endometrial cancer. Medical disease including DM and HTN are common medical problems in patients with post menopausal bleeding these are significantly associated with endometrial cancer, but a causal relationship not been confirmed yet [34] . It is important to mention that all risk factors are based on probabilities, and even someone without any risk factors can still get endometrial cancer. Cervical carcinoma is vastly more common in developing countries; there are several known risk factors for getting cervical cancer. One of the most important risk factors for cervical cancer is infection with a virus called HPV. HPV which is the virus that causes genital warts, but having genital warts doesn't necessarily mean you are going to get cervical cancer. However, almost all cervical cancers have evidence of HPV virus in them. In this study this has not been assessed because of unavailability of HPV studying. Any risk factors for developing sexually transmitted diseases are also risk factors for developing cervical cancer. Another important risk factor for developing cervical cancer is smoking. In this study only one case had cervical cancer, she was smoker, and we don't have adequate power to definitively test actual risk of smoking on cervical cancer. In this study the clear span divided in 4 phases, it was observed that hyperplasia predominantly observed in phase one as result by other [35] . The incidence of malignancy increases with delay in presentation, while incidence of atrophic changes & cervicitis appears mostly in phase 1 & 3. In general with advancing in age, the incidence of bleeding decreases which represents phase 3 & 4 of clear span, in phase 4 only (12.1%) of cases were present while phase one represents( 45.2% ) 0f cases. As shown in this study endometrial hyperplasia with or without atypia was the predominant finding in about (45%) of cases which is higher than the result of many other studies [36] . Frequency percentage of cervical and endometrial polyp together was about (31.4%) in this study which is higher than that reported by others [37] .
Frequency percentage of atrophic endometritis-vaginitis was (9.9%) of cases. The exact cause of bleeding from atrophic endometritis isn"t known, it may be due to anatomic vascular variation or local haemostatic mechanism [38] . The absolute risk of endometerial cancer in non-user of HRT who present with PMB ranges from (5.7-11.5%) [7] , the frequency percentage of endometrial carcinoma is (9.28%) in this In this study the frequency percentage of Cervical cancer is (0.7%). Exogenous estrogen: the percentage is zero, this is most likely due to small number of women in our society that use HRT in postmenopausal years due to lack of awareness about its advantages. The frequency percentage of cervicitis-CIN was (15.7%), which was the 3rd etiology of postmenopausal bleeding in this study, which is higher than other study [39] . There is no evidence to indicate whether different patterns of PMB such as one-off bleeding or more frequent bleeds are more likely to be associated with malignancy [40] . Women with recurrent PMB after initial negative investigations are no more likely to have endometrial cancer than those presenting for the first time but re-investigation is indicated if six months has elapsed [41] . Longer lasting bleeding episodes, higher amount of bleeding and recurrent bleeding episodes were the clinical characteristics associated with endometrial cancer [42] . In this study (53.9%) of patients with endometrial cancer had sever uterine bleeding, while (19%) of patients with endometrial hyperplasia had sever PMB and (38.43%) of patients with endometrial cancer had prolonged PMB>6month. The incidence of recurrent PMB was (25.47%), of these, (10%) had endometrial cancer, (40%) of the patients with recurrent PMB had endometrial hyperplasia in this study.
Conclusions
Majority of cases with post menopausal bleeding were having benign causes 90%, however malignancies were very important etiology of bleeding in this age group, it constitute 10%. Malignant cases were either endometrial cancer (9.3%) or cervical cancer (0.7%), obesity was significant morbidity in this age group. 
